HUGE.CN - FSD Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
7.76
-0.53 (-6.39%)
As of 12:28PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close8.29
Open8.05
Bid7.77 x 0
Ask8.00 x 0
Day's Range7.39 - 8.25
52 Week Range4.40 - 73.36
Volume31,744
Avg. Volume43,528
Market Cap60.654M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-6.93
Earnings DateAug. 29, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors

    FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced that it has appointed Larry Kaiser, MD, FACS to its Board of Directors, effective immediately. Dr. Kaiser will also continue to serve as the Chairman of FSD Pharma’s Scientific Advisory Board (SAB).

  • CNW Group

    FSD Pharma to Ring Nasdaq Opening Bell on Wednesday, January 22, 2020

    TORONTO , Jan. 17, 2020 /CNW/ - FSD Pharma Inc. (HUGE.CN) (HUGE.CN) (FRA: 0K9) ("FSD Pharma" or the "Company") is pleased to announce that Executive Co-Chairman and CEO Dr. Raza Bokhari , along with the founders, members of the Company's Board of Directors, members of the leadership team, early investors, advisors, and other stakeholders, will ring the Nasdaq Stock Market opening bell on Wednesday, January 22, 2020, at 9:30 am ET. The Opening Bell Ringing Ceremony will be held at Nasdaq's MarketSite in New York City and will be webcast live beginning at 9:20 am ET via the following link: https://www.nasdaq.com/marketsite/bell-ringing-ceremony and live streaming will be available on Facebook at the following link: http://Facebook.com/Nasdaq. "It will indeed be a unique privilege for me to ring the opening bell at Nasdaq to commence trading in the presence of FSD Pharma's extended family and friends," said Raza Bokhari , MD, Executive Co-Chairman and CEO.

  • InvestmentPitch Media Video Discusses FSD Pharma's New Listing on the  Nasdaq Capital Market and Upcoming Biotech and Healthcare Conferences - Video Available on Investmentpitch.com
    Newsfile

    InvestmentPitch Media Video Discusses FSD Pharma's New Listing on the Nasdaq Capital Market and Upcoming Biotech and Healthcare Conferences - Video Available on Investmentpitch.com

    Vancouver, British Columbia--(Newsfile Corp. - January 10, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D company, has started trading on the Nasdaq Capital Market under the symbol "HUGE". FSD Pharma is focused on developing, over time, a robust pipeline of FDA approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of ...

  • Business Wire

    INSERTING and REPLACING FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol ‘HUGE’

    Insert in second paragraph, first sentence of release: Executive Co-Chairman and CEO.

  • FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol 'HUGE'
    CNW Group

    FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol 'HUGE'

    - Management to Present at Biotech Showcase 2020 - TORONTO , Jan. 9, 2020 /CNW/ - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company") announced that ...

  • Business Wire

    FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol ‘HUGE’ on January 9, 2020

    FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD Pharma" or the "Company") today announced that its Class B Subordinate Voting Shares (the "Shares") have been approved for listing on the NASDAQ Capital Market ("NASDAQ") under the symbol ‘HUGE’. Trading on the NASDAQ is expected to commence at market open on Thursday, January 9, 2020.

  • FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol 'HUGE' on January 9, 2020
    CNW Group

    FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol 'HUGE' on January 9, 2020

    Trading on the NASDAQ is expected to commence at market open on Thursday, January 9, 2020 . The Company's Shares will continue to be listed on the Canadian Securities Exchange under the symbol 'HUGE'.

  • Business Wire

    FSD Pharma Strengthens Management Team

    FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD Pharma" or the "Company") today announced the appointments of three key executives: Donal Carroll, Chief Financial Officer. Mr. Carroll previously served as interim CFO; Sandra Lottes, Pharm D, Vice President & Head of Clinical Research of FSD Pharma’s BioSciences Division; and Shahzad Shah, Chief Operating Officer of FV Pharma.

  • InvestmentPitch Media Video Discusses FSD Pharma's Approval of Listing Application for Nasdaq Capital Market with trading Anticipated to Begin Shortly - Video Available on Investmentpitch.com
    Newsfile

    InvestmentPitch Media Video Discusses FSD Pharma's Approval of Listing Application for Nasdaq Capital Market with trading Anticipated to Begin Shortly - Video Available on Investmentpitch.com

    Vancouver, British Columbia--(Newsfile Corp. - December 17, 2019) - FSD Pharma Inc. (CSE: HUGE) (FSE: 0K9) (OTCQB: FSDDF), a specialty, biotech pharmaceutical R&D company, reports its application to list its Class B Subordinate Voting Shares on the Nasdaq Capital Market has been approved by Nasdaq and the company anticipates trading on Nasdaq to begin shortly. FSD Pharma is focused on developing a robust pipeline of FDA approved synthetic compounds targeting the endocannabinoid system of ...

  • CNW Group

    IIROC Trade Resumption - HUGE

    VANCOUVER , Dec. 16, 2019 /CNW/ - Trading resumes in: Company: FSD Pharma Inc. CSE Symbol: HUGE All Issues: Yes Resumption (ET): 9:30 AM IIROC can make a decision to impose a temporary suspension (halt) ...

  • FSD Pharma Receives Approval to List its Shares on Nasdaq
    CNW Group

    FSD Pharma Receives Approval to List its Shares on Nasdaq

    FSD Pharma Receives Approval to List its Shares on Nasdaq

  • Business Wire

    FSD Pharma Receives Approval to List Its Shares on Nasdaq

    FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD Pharma" or the "Company") announces that Nasdaq has approved its application to have its Class B Subordinate Voting Shares (the "Shares") listed on the Nasdaq Capital Market ("Nasdaq"). FSD Pharma expects the Shares to commence trading on Nasdaq in the near future.

  • CNW Group

    IIROC Trading Halt - HUGE

    VANCOUVER , Dec. 13, 2019 /CNW/ - The following issues have been halted by IIROC: Company: FSD Pharma Inc. CSE Symbol: HUGE (all issues) Reason: At the request of the Company Pending News Halt Time (ET): ...

  • FSD Pharma to Present at Investor Summit on December 17
    CNW Group

    FSD Pharma to Present at Investor Summit on December 17

    Mr. Bokhari will be available during the day on December 17 for one-on-one meetings. Mr. Bokhari's presentation will be webcast live and available for replay on the 'Events and Presentations' section of the 'Investors' page of the FSD Pharma website, www.fsdpharma.com, or via https://www.webcaster4.com/Webcast/Page/2038/32606.